Close
Digital Health & Ai Innovation summit 2026
Medical Taiwan 2026

Cancer care lacks Alarming failures among breast cancer patients

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

China Approves First Commercial Brain-Computer Interface

China has granted approval for the commercial sale of...

MiniMed 780G System Gains CE Mark...

MiniMed Group, a global provider of integrated insulin delivery...

SmartHeart, the Cardiac MR Suite by...

Philips received FDA 510(k) clearance for SmartHeart, which happens...

Women are twice as likely to die from breast cancer in some parts of the country amid “alarming” failings by NHS services, experts have warned.

A report by the All-Party Parliamentary Group on Breast Cancer reveals a “postcode lottery” in screening, diagnosis and death rates from the disease.
Sufferers said they had been put through “absolute hell” amid long waits for diagnosis, with critical shortages of staff.

The report warns that women in some parts of the country are twice as likely as those elsewhere to die from breast cancer before the age of 75.

The worst rates were in Newark and Sherwood clinical commissioning group (CCG), with 31.9 per 100,000 people dying from breast cancer before the age of 75, compared with 13.3 per 100,000 in Tower Hamlets CCG.

The report also shows wide variations in early detection of the disease. In Gloucestershire, less than 62 per cent of cancers were detected at stage one or two, compared with 88 per cent in the best-performing area of Rushcliffe CCG.

MEDICAL FAIR ASIA 2026

Latest stories

Related stories

China Approves First Commercial Brain-Computer Interface

China has granted approval for the commercial sale of...

MiniMed 780G System Gains CE Mark for Abbott Instinct Sensor

MiniMed Group, a global provider of integrated insulin delivery...

SmartHeart, the Cardiac MR Suite by Philips Gets Clearance

Philips received FDA 510(k) clearance for SmartHeart, which happens...

Medtronic Neurovascular Portfolio Strengthens with Scientia

Medtronic, on March 10, 2026, announced a definitive agreement...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »